Trials / Completed
CompletedNCT02627950
Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- University of Luebeck · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current prospective, randomized, controlled MonAMI trial aims to systematically examine the effects of morphine on the platelet inhibitory effects of the orally administered platelet inhibitor ticagrelor in patients with acute myocardial infarction. In addition, the potential positive or negative effects of MCP in combination with morphine on platelet inhibition will be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphinhydrochloricum | 5 mg morphine intravenously |
| DRUG | Metoclopramide | 10 mg MCP intravenously |
| DRUG | Ticagrelor | 180 mg ticagrelor orally |
| DRUG | Isotonic sodium chloride | 10 ml NaCl 0.9% intravenously |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2015-12-11
- Last updated
- 2019-08-08
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02627950. Inclusion in this directory is not an endorsement.